CHIEF EXECUTIVE OFFICER (CEO), ALPS GROUP
谭铖洸医学博士 是生命科学领域的资深人士，对细胞治疗领域充满着热忱。不仅如此，谭博士学富五车，在厦门大学获得了医学学士学位，从美国宾州管理学院获得工商管理硕士，获广州中医药大学授予肿瘤学（中西结合）临床医学博士学位。
自 2006 年以来，他积极地参与一项正关于抗衰老细胞疗法的广泛研究，他同时也和瑞士及亚洲同行保持密切合作，推进人们对细胞疗法的认知，并渴望分享他在这领域的见识和经验。
除此之外，他还积极参与癌症研究。他重要的科学突破之一是发现了酪氨酸酶抑制剂，可减少黑色素的产生，从而达到皮肤美白。在他最近出版的刊物中提到，成功构建逆转录病毒转染系统可开发作为肝癌基因治疗的手段。
身为集团的首席执行官以及首席科学家，谭博士将成为推动集团迈向更高峰的核心人物，并会 积极发展集团成为一家受国际认证的生物科技公司。
CHIEF OPERATION OFFICER (COO), ALPS GROUP
Ms. Lisa TEOH is a project leader and has over 27 years of experience in successfully delivering large complex infrastructure & property projects in the Asia Pacific region, including Australia and Dubai. She is a civil engineer registered with professional institutions in Malaysia and an ASEAN Chartered Professional Engineer. She graduated in 1995 from the University of Oxford, United Kingdom, with a Master’s Degree in Engineering Science (Civil), specialising in civil / construction / structural / production operations, and QAQC. She led diverse teams of multidiscipline and multinational consultants & specialists in delivering varying projects for property/land development, roads, airports, and desalination plants. During recent years, she had also led a large contractor’s team in delivering and recovering distressed projects.
Chief Scientific Officer (CSO)
Prof M. Ravichandran obtained his M.Sc. Medical Microbiology from Christian Medical College, Vellore, India, and gained his PhD in Biotechnology from Anna University, Chennai, India. His research interests are Human lymphatic filariasis, genetically engineered cholera vaccine and formulation, Covid-19 vaccine and drug development, molecular diagnostics and phage therapy. He has 80 publications in international journals with 2027 citations and an h-index of 25. He has supervised 55 MSc/PhD students and examined 65 postgraduate students locally and internationally. He has filed 14 patents. On product development, he successfully technology transferred EZDNA Amp diagnostic technology and commercialised three products on diagnostics. He has written over 21 articles in the press, and he is a New Strait Time (NST) columnist.
Previously Prof Ravi was the former Chief Executive and Vice-Chancellor of AIMST University, Malaysia. He was also the Chairman of Covid-19 Task force at AIMST University. He holds director positions at Vax Biotech Sdn Bhd, Malaysia, which is a spin-off company of his cholera vaccine patent. He has been awarded 50 national and international awards for academic and research excellence, including Ideas Inventions New Products – (IENA), Nuremberg Germany; International Exhibition of Inventions: New Technologies and Products, Geneva and National Innovation Award, Malaysia. He was an associate member and the Committee member on ‘TOP RESEARCH SCIENTISTS MALAYSIA’ (TRSM) of the Academy of Sciences Malaysia (ASM).
阿尔卑斯医学中心高级医疗主任兼整形外科医生
班杰明 • 乔治Jr. 医生 是班杰明•乔治Sr.的长子。获爱尔兰国立大学授予医学学士学位、外科学士学位和产科学士学位。1983年也获得爱尔兰皇家内外科学院执照。1990年，从英国爱丁堡皇家外科医学院获得研究生学位。英国爱丁堡皇家外科医学院是其中一家古老的外科医学院，由King James IV （译：英格兰国王 – 詹姆斯四世）创立于1505年。
班杰明•乔治Jr.医生在英格兰罗奇代尔Birch Hill Hospital开启了他杰出的职业生涯。一开始他担任普通外科医生，后来调任为血管外科医生，再后来肾脏专科。他后来转往英国知名的Royal Preston Hospital（译：皇家普雷斯顿医院）担任普通外科医生，到后来的泌尿外科，骨科和心胸外科。
班杰明•乔治Jr.医生目前在吉隆坡鹰阁医院和乔治医美整形诊所担任整形外科顾问医生。他也是吉隆坡焦赖班台医院外聘整形外科顾问医生。 拥有超过30年当不同医疗领域医生的经验和超过22年的整形外科经验，加上曾在国际和本地知名的医院担任医生，班杰明•乔治Jr.医生无疑是一位深受欢迎的医生。本地电视台也多次对他进行关于整形外科专业知识的专访。
班杰明•乔治Jr.医生在1995年授予Academy of Medicine of Malaysia（译：马来西亚医学院）的荣誉会员。他也从新加坡Lee Community College获得心理学文凭。Lee Community College被新加坡Edupoll评选为最佳私立心理学学院。
